热门资讯> 正文
Eledon Pharmaceuticals GAAP EPS—0.32美元击败0.07美元
2024-03-29 05:09
- Eledon Pharmaceuticals press release (NASDAQ:ELDN): Q4 GAAP EPS of -$0.32 beats by $0.07.
- The Company ended the year with approximately $51.1 million in cash and cash equivalents and short-term investments, compared to $56.4 million in cash and cash equivalents as of December 31, 2022.
More on Eledon Pharmaceuticals
- World’s first pig-to-human kidney transplant performed in U.S
- Eledon Pharmaceuticals reports recent business milestones
- Seeking Alpha’s Quant Rating on Eledon Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
